Atlas Trials

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

RecordFirmDate
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (NCT04281472)argenx2020-04-15
Panzyga in CIDP Administered at Different Infusion Rates (NCT03166527)Vera Bril2017-06-01
Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT02027701)CSL Behring2014-07-30
CIDP07 Rozanolixizumab Post Trial Access Program (the PTA) (NCT05014724)UCB Biopharma SRL
Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT04777734)argenx

Track Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) automatically

Every clearance here is in the API, with alerts when new ones post.